Tingling and Dizziness After Therapeutic Apheresis: Why They Happen and What to Report

The chair reclines, the machine hums, and somewhere in the second hour a patient notices her lips have started to buzz, the way a foot does when it has been sat on too long. She wonders whether to mention it. The nurse, who has seen this a hundred times, already has the saline hanging and a question ready: “Fingertips too?”

Plasmapheresis side effects tingling is one of the most typed searches by people who have just finished a first exchange, and the honest answer is more reassuring, and more specific, than most online pages let on. Tingling and dizziness are not random. They come from identifiable chemistry and physics inside the circuit, and each has a recognizable pattern, a usual duration, and a small set of signs that mean something else is going on.

This explainer walks through what actually happens to your blood during an exchange, why your mouth and hands react first, why standing up afterward can feel like stepping off a boat, and which symptoms deserve a same-day phone call rather than a shrug.

What actually happens during therapeutic apheresis

Therapeutic apheresis is the general term for any procedure that draws blood out of the body, separates it into parts, removes or treats one part, and returns the rest. Plasmapheresis, also called therapeutic plasma exchange or PLEX, is the version most patients meet: the liquid plasma is removed and replaced, while red cells, white cells and platelets go back.

The circuit begins with access. Blood leaves through a needle in a large arm vein or through a central venous catheter, a soft tube placed in a large vein of the neck, chest or groin when arm veins are not adequate. It flows into a machine that separates the plasma either by spinning it in a centrifuge or by pushing it across a fine membrane filter. The plasma, carrying antibodies, abnormal proteins and other dissolved substances, is diverted to a waste bag. The cells are mixed with replacement fluid, usually a protein solution called albumin or, in some conditions, donor plasma, and returned through a second line.

Two numbers explain most of what you feel. First, at any moment a modest volume of your blood is outside your body in the tubing and separation chamber, and this extracorporeal volume can nudge blood pressure downward, especially in smaller or frailer patients. Second, the machine cannot let blood clot inside the circuit, so it adds an anticoagulant, most often a citrate solution, at the point where blood leaves the body. Citrate works by binding calcium, which clotting needs. That binding is the direct source of the tingling most people notice, and we return to it in the next section.

A single exchange typically removes one to one and a half times the patient’s estimated plasma volume and takes roughly two to four hours, according to the NIH StatPearls review and Cleveland Clinic patient information. Most treatment plans involve a series of sessions rather than a single one, spaced by the treating team according to the condition.

Plasmapheresis side effects: why tingling is the one most people notice

Ask an apheresis nurse which symptom patients report first, and the answer is nearly always the same: a fizzing or numb feeling around the lips, then the fingertips, sometimes the toes. The medical term is paresthesia, meaning an abnormal skin sensation without an obvious cause, and in this setting the cause is not mysterious at all.

Citrate binds calcium. Roughly half the calcium in your blood is “ionized,” or free and chemically active; the rest is attached to proteins. Nerves and muscles rely on the free portion to control how easily they fire. When citrate-anticoagulated blood is returned to you faster than your liver and kidneys can metabolize the citrate, the free calcium level dips. Nerve membranes become more excitable, and the most densely innervated, sensitive areas announce it first: the mouth, the hands, the feet.

This is why the pattern is so characteristic. It tends to begin in the second half of a session, when citrate has been accumulating. It is symmetrical, affecting both sides. It rarely involves weakness. Cleveland Clinic’s overview of low blood calcium lists exactly these sensations, along with muscle cramps or twitching, as the earliest signs when levels fall.

Several things influence how strongly a person feels it. Faster blood flow rates deliver citrate more quickly. Donor plasma as replacement fluid contains citrate of its own, adding to the load, which is one reason exchanges for conditions that require plasma replacement, such as thrombotic thrombocytopenic purpura, are watched closely for citrate effects. Impaired liver function slows citrate clearance. A low starting calcium, low magnesium, or simply a small body size also raise the odds.

The practical point is that this tingling is expected, recognized and manageable within the session. Teams commonly adjust the citrate rate or give calcium in a form and amount they determine, and the sensation usually fades within minutes to an hour or two once the citrate is cleared, as described in the StatPearls review of complications.

Plasma exchange dizziness: the mechanics behind the spinning room

Dizziness during or after an exchange is less about your inner ear and more about plumbing. Three overlapping mechanisms account for nearly all of it.

The first is volume. Even when the machine returns fluid at the same rate it removes plasma, a portion of your blood sits in the tubing, and replacement fluids do not always hold water in the bloodstream exactly the way your own plasma did. Albumin solutions are good at this; saline is less good, and some protocols mix the two. A short-lived drop in blood pressure, called hypotension, is among the more frequent events in large procedure series reviewed by StatPearls, and light-headedness is its most common symptom.

The second is the vagal reflex. Needle placement, anxiety, an empty stomach and a cool room can trigger a reflex that slows the heart and widens blood vessels. People describe it as a wave of warmth, nausea, and a feeling that the floor has softened. It is the same reflex behind fainting at a blood draw, and it responds to lying flat and raising the legs.

The third is chemistry again. Very low ionized calcium can produce not only tingling but a woozy, unsteady sensation, and the two often travel together. If a patient is dizzy and tingling at the same time, citrate is the usual suspect; if dizzy without tingling, volume or a vagal response is more likely.

After the session, a different factor takes over. Standing quickly after two to four hours reclined, sometimes without a proper meal, invites orthostatic dizziness, the momentary drop in pressure to the brain when you rise. It is why most units ask you to sit up slowly, dangle your legs, and stand with someone nearby.

Mayo Clinic’s patient information on plasmapheresis for myasthenia gravis lists a drop in blood pressure alongside bleeding and rhythm disturbances as the main procedural risks, which matches what apheresis teams watch for minute by minute.

What is the most common complication of plasmapheresis?

Across the large published series summarized in the NIH StatPearls review, the most frequently recorded complications are citrate-related symptoms (tingling, cramping, nausea) and transient low blood pressure. These two categories account for the bulk of events, and the overwhelming majority are classified as mild and resolve during or shortly after the procedure.

It helps to sort complications into groups, because they arise from different parts of the process.

• Anticoagulant effects: low ionized calcium from citrate, occasionally low magnesium, and in people receiving heparin, a small increase in bleeding tendency.
• Volume and pressure effects: hypotension, light-headedness, and, less often, fluid overload in people with heart or kidney limitations.
• Replacement fluid reactions: hives, itching, flushing or chills, more common with donor plasma than with albumin, and very rarely a serious allergic reaction.
• Access-related problems: bruising, pain or infection at a needle or catheter site, and, with central catheters, clotting or air entry, which are uncommon but taken seriously.
• Removal of things you wanted to keep: clotting factors, immunoglobulins and some medicines leave with the plasma, which can temporarily raise bleeding and infection risk and may affect drug timing.

The overall complication rate in modern series is in the low single-digit percentages per procedure, with serious events far rarer, according to the StatPearls summary of the literature. That number is worth holding onto when a search result frames apheresis as “surgery.” It is not surgery. There is no incision beyond needle access, no anesthesia, and no recovery room in the surgical sense.

None of this means complications should be dismissed. The nurse asking about your fingertips every twenty minutes is running an active surveillance program, and your honest answers are part of it.

Who usually has therapeutic apheresis, and who is asked to wait

Plasma exchange is used when something dissolved in the plasma is causing harm and there is value in removing it quickly, either as a bridge while slower treatments take hold or as a treatment in its own right. Within cancer care, the clearest example is hyperviscosity syndrome, in which an abnormal protein produced by conditions such as Waldenström macroglobulinemia or multiple myeloma thickens the blood and impairs circulation to the brain, eyes and kidneys. Some paraneoplastic neurological syndromes, where a tumor provokes antibodies that attack the nervous system, are also considered for exchange.

Beyond oncology, the NHS describes plasma exchange as a first-line treatment for Guillain-Barré syndrome, and Mayo Clinic lists it among options for myasthenia gravis crises. Thrombotic thrombocytopenic purpura, certain kidney diseases driven by antibodies, and preparation for some transplants are other established uses. The American Society for Apheresis grades indications by evidence strength, and treating teams generally follow those categories.

Who is asked to wait, or offered an alternative? The decision always belongs to the treating team, but the usual pauses include:

• An active infection, particularly at a potential catheter site.
• Unstable blood pressure or a recent heart event, because the volume shifts of an exchange add strain.
• A severe allergy to albumin or plasma products, where alternatives to the replacement fluid must be arranged first.
• Uncorrected low calcium or a bleeding disorder that would be worsened by citrate or clotting-factor removal.
• Medicines that the exchange would strip from the bloodstream, where timing needs to be coordinated with the prescriber.

For some conditions, intravenous immunoglobulin or immune-suppressing medicines offer a comparable route with a different side-effect profile, and the NHS notes that for Guillain-Barré syndrome the two approaches are considered similarly effective. Which fits an individual depends on the diagnosis, other health conditions, vein access, and how quickly the plasma component needs to come down.

Common side effects of PLEX at a glance

People who have just been told they need a course of exchanges often want a single view of what to expect, how long each effect tends to last, and what the team does about it. The table below draws on the Cleveland Clinic, Mayo Clinic and NIH StatPearls summaries. Durations are typical ranges reported in those sources, not promises for any one person.

Effect	Usual cause	Typical timing and duration	How teams usually respond
Tingling of lips, fingers, toes	Citrate lowering free calcium	Begins mid-session; fades within minutes to a few hours	Slow citrate delivery, give calcium, check levels
Light-headedness, faintness	Fluid shift, vagal reflex, low pressure	During or shortly after; usually resolves within an hour	Recline, fluids, pause or slow the run
Muscle cramps or twitching	Low calcium or magnesium	During session; eases as levels correct	Correct electrolytes
Chills, hives, itching	Reaction to replacement fluid, usually plasma	Within minutes of exposure	Pause, antihistamine-class medicine per protocol
Fatigue	Protein and fluid shifts, long session	Same day to 1–2 days	Rest, nutrition, hydration
Bruising or soreness at access site	Needle or catheter	Several days	Site care, monitoring for infection
Easier bruising or bleeding	Clotting factors removed with plasma	Recovers over roughly 24–48 hours	Labs before next session; plasma replacement if needed

Notice what is missing from the table: severe, lasting harm. Serious allergic reactions, significant bleeding, dangerous heart rhythm changes and catheter infections do occur, but they are uncommon events that teams screen for before, during and between sessions. Notice too that fatigue, which almost nobody warns you about, is nearly universal after a long run and usually lifts within a day or two.

How risky is plasmapheresis, honestly?

The fairest framing is this: plasma exchange is an intensive procedure with a low rate of serious harm when performed by trained teams, and the risk profile is shaped more by the patient’s underlying condition and access route than by the exchange itself.

Large procedure series reviewed in the NIH StatPearls chapter report overall adverse events in the low single-digit percentage range, with the majority mild and citrate- or pressure-related. Serious events, including major allergic reactions, significant bleeding and life-threatening rhythm disturbances, are described as rare, and procedure-related deaths as very rare, occurring almost exclusively in critically ill patients whose underlying illness was itself life-threatening.

Three variables move the needle more than any other.

Access is the first. Peripheral arm veins carry the lowest complication risk. Central venous catheters add the possibility of insertion injury, clot formation and bloodstream infection. When a catheter is required, the team weighs that against the alternative of not treating quickly enough.

Replacement fluid is the second. Albumin, a purified protein solution, rarely causes allergic reactions and carries no infectious risk. Donor plasma provides clotting factors and is essential in certain conditions, but it brings a higher rate of allergic and febrile reactions and a small, carefully screened residual risk that applies to any blood product.

The patient’s reserve is the third. Someone with a strong heart, normal kidneys and stable blood pressure tolerates fluid shifts easily. Someone with heart failure, a recent heart attack, or advanced kidney disease has less margin, and teams adjust volumes, rates and monitoring accordingly.

Mayo Clinic’s patient information lists the recognized risks plainly: a drop in blood pressure, bleeding, heart rhythm problems, muscle cramps and allergic reaction. Those are the honest headline risks. What the internet tends to add, dramatic stories of permanent damage from a routine exchange, is not what the published series show.

How long do plasmapheresis effects last?

This question actually contains two: how long do the side effects last, and how long does the treatment effect last. They have different answers.

Side effects are short. Citrate is metabolized by the liver, muscle and kidneys within hours, so tingling and cramping generally resolve within the session or shortly after, as the Cleveland Clinic and StatPearls summaries describe. Dizziness from pressure drops typically settles within an hour of lying flat and receiving fluid. Fatigue is the outlier, lingering for a day or two in many people, especially after back-to-back sessions. Bruising at a needle site follows the ordinary timeline of any bruise.

The treatment effect is a matter of arithmetic and biology. A single exchange of one plasma volume removes roughly 60 to 65 percent of a substance that lives in the bloodstream, according to the StatPearls review. Substances that also sit in tissues, which includes most antibodies, then drift back into the blood over the following one to two days as the body re-equilibrates. That is why exchanges are scheduled in a series, often every day or every other day, to pull the level down step by step faster than it rebounds.

How long the benefit persists after a course depends on what is being removed and whether the body keeps making it. For an antibody produced by an ongoing immune process, levels will climb back over weeks unless another treatment slows production, which is why exchange is often paired with immune-modulating medicines chosen by the treating team. For a one-time toxin or a protein whose source has been treated, the effect may be durable.

People treated for Guillain-Barré syndrome, for instance, generally recover over weeks to months, and the NHS is explicit that plasma exchange shortens the illness and improves outcomes without producing an instant reversal. The honest expectation is a gradual trend, not a switch.

Citrate reaction after plasmapheresis: when tingling stops being routine

Most tingling is a nuisance. Some tingling is a message. Learning to tell the difference is the single most useful skill a patient can bring to a course of exchanges.

Routine citrate paresthesia is symmetrical, starts around the mouth or fingertips, appears mid-session, and eases as the run slows or calcium is given. It does not come with weakness, confusion or trouble breathing.

The progression that teams watch for is described in the Cleveland Clinic overview of low blood calcium. When ionized calcium continues to fall, tingling gives way to muscle cramps, then to involuntary spasms of the hands and feet in which the fingers draw together and the wrists flex, a sign called carpopedal spasm. Nausea, a metallic taste, chest tightness, and a sense of the heart pounding or skipping can follow. At very low levels, spasm of the airway muscles or changes in heart rhythm become possible. These are the reasons apheresis units treat early tingling rather than waiting.

Timing matters too. Tingling that begins hours after the session ends, rather than during it, is less likely to be citrate, which is cleared quickly, and more likely to point toward something else: an electrolyte disturbance from another cause, a medicine effect, or a symptom of the underlying condition. Tingling on one side of the body, tingling in a single limb, or tingling accompanied by weakness or facial droop is not a citrate pattern and warrants urgent assessment.

People with the neurological conditions most often treated by exchange, such as Guillain-Barré syndrome or myasthenia gravis, already live with altered sensation and strength. That makes a clear baseline important. Telling the team on day one exactly where you already feel numb, and how strong your grip normally is, gives them something to compare against when new symptoms appear.

What the following days and weeks usually look like

The first evening after an exchange tends to be quiet. Most people feel tired in a way that is out of proportion to sitting in a chair for three hours; the body has just replaced a large share of its plasma proteins and shifted several liters of fluid around. Eating a normal meal, drinking to thirst, and going to bed early is a reasonable plan. Bruising at an arm access site may appear over the next day.

For a course delivered on consecutive or alternate days, the pattern repeats with small variations. Blood tests before each session check calcium, clotting measures, platelets and often fibrinogen, a clotting protein that leaves with the plasma. If fibrinogen has dropped too low, the team may switch part of the replacement to plasma or delay a session; that is standard protection, not a sign of trouble. Cumulative fatigue is common by the third or fourth session, and many people find the tingling either lessens as the team fine-tunes citrate delivery or becomes predictable enough to stop worrying about.

Catheter care is the main homework for anyone with a central line: keeping the dressing dry and intact, watching the skin around it, and checking temperature if feeling unwell. Any fever with a central catheter in place is treated as urgent until proven otherwise.

The treatment effect itself unfolds over a different timescale. For antibody-driven conditions, symptom changes may begin within days but usually build over one to several weeks, and the NHS describes recovery from Guillain-Barré syndrome in terms of weeks to months even with treatment. Improvement is rarely linear; a good day followed by a flat one is normal.

Follow-up visits check that the removed substance is staying down, that any paired medicines are working, and that clotting and immune proteins have recovered. Because immunoglobulins fall with each exchange, some people are more prone to minor infections for a few weeks, another reason to report a fever promptly.

Medicines, clotting and the fluid you get back: what shapes your reaction

Two people can sit in identical chairs, connected to identical machines, and have very different afternoons. The differences usually trace to what is in the return line and what is already in their bloodstream.

Replacement fluid comes first. Albumin, a purified protein solution, is the default in most conditions because it holds fluid in the vessels well and rarely provokes allergy. It contains no clotting factors, so after several albumin-based exchanges, clotting measures drift and easy bruising can appear until the liver restores the balance over a day or two. Donor plasma restores clotting factors and is required in conditions such as thrombotic thrombocytopenic purpura, but it carries more citrate, meaning more tingling, and a higher rate of allergic reactions such as hives, itching and chills. Teams often give an antihistamine-class medicine beforehand when plasma is used; the choice and timing are theirs.

Anticoagulant comes second. Citrate is preferred because its effect ends the moment blood returns to the body and mixes with the body’s calcium stores. Heparin, an anticoagulant that works throughout the whole body, is used in some circuits, particularly membrane systems. It avoids the tingling but slightly raises bleeding tendency for a few hours afterward.

Your own medicines come third. Drugs that are largely protein-bound and stay in the bloodstream can be partially removed by an exchange. Some immune-suppressing medicines, certain antibiotics and some anticonvulsants fall into this category. Prescribers frequently schedule doses after a session rather than before, or check levels; this is a coordination task for the treating team, and no patient should adjust timing on their own.

Blood pressure medicines deserve a mention. Because the exchange itself can lower pressure, some teams ask patients to hold a morning dose, and others do not. Ask rather than assume, and never change a prescribed medicine without that conversation.

Small things that make a session easier

Apheresis nurses accumulate a folk wisdom about comfort that rarely appears in textbooks. Most of it is grounded in the mechanisms already described.

Eat beforehand. Arriving with an empty stomach lowers blood sugar and primes the vagal reflex that causes faintness. A normal meal an hour or two before, unless the team says otherwise, steadies both. Some units suggest calcium-containing foods, such as dairy or fortified alternatives, on treatment days; whether any calcium supplement is appropriate is a decision for the team, since the timing and form matter and the effect on citrate symptoms is only partly predictable.

Drink to thirst. Being mildly dehydrated makes veins harder to access and blood pressure more likely to sag. Overdoing fluids is not helpful either, particularly for anyone with heart or kidney limitations, so “normal” is the target.

Dress in layers. Blood cooled in the tubing returns a degree or two cooler, and chills are common in the second hour. Warm blankets are standard issue; ask for one before you need it.

Speak up early. The first flicker of lip tingling is the moment to say so, not the point at which your hands cramp. Teams can slow the citrate, give calcium, or adjust the run far more easily when the change is small.

Move deliberately afterward. Sit up for a few minutes, dangle your legs, then stand with someone close. The first walk to the bathroom is when orthostatic dizziness strikes.

Plan the evening. Arrange a ride home; fatigue and residual light-headedness make driving unwise after a long session, and many units ask that you not drive yourself. Keep the next day light if you can.

Keep a simple log of what you felt, when it began and what helped. Over a course of exchanges that record helps the team tailor each run to you.

What people often get wrong

Search results for apheresis are a strange mix of insurance codes, device reports and half-remembered patient forums. A few misunderstandings recur.

“Plasmapheresis is surgery.” It is not. Access is by needle or a catheter placed under local anesthetic; there is no incision, no general anesthesia, and no operating room. The word “surgery” attached to it online is a search-engine artifact, not a medical description.

“Tingling means the machine is hurting my nerves.” The tingling is a chemical effect of citrate on calcium, reversible within hours. Nerves are not being damaged by the procedure. The confusion is understandable in people whose underlying condition, such as Guillain-Barré syndrome, does involve nerve injury, which is why establishing a baseline matters.

“My whole blood is being replaced.” Only the plasma fraction is exchanged. Red cells, white cells and platelets are returned, minus a small unavoidable loss.

“One session should fix things.” A single exchange removes roughly 60 to 65 percent of a bloodstream substance, per the StatPearls review, and tissue stores refill the blood over the next day or two. Courses are planned as a series for that reason, and improvement in the underlying condition usually builds over weeks.

“Leg jerks and cramps mean something has gone badly wrong.” Muscle twitching and cramping during or after a session are classic low-calcium or low-magnesium signs and are usually corrected quickly. They should always be reported, but they are on the expected list, not the alarming one.

“Dizziness afterward means I lost too much blood.” Blood loss during exchange is minimal. Post-session dizziness is almost always fluid shift, a vagal response, or standing too quickly.

“Apheresis removes my other medicines, so I should take extra.” Some medicines are partly removed, but the response is coordinated timing arranged by the prescriber, never a self-adjusted dose.

Questions to ask your care team

A first exchange goes more smoothly when the patient understands the plan well enough to notice when something departs from it. These questions are drawn from what people most often wish they had asked.

• Which type of access will I have, peripheral veins or a central catheter, and how do I care for the site between sessions?
• What replacement fluid will be used, albumin or plasma, and what does that mean for tingling, allergy risk and clotting?
• Which anticoagulant runs in the circuit, and what should I do at the first sign of tingling or cramping?
• How many sessions are planned, how far apart, and what result or blood test will tell you the course is working?
• Which of my regular medicines might be removed by the exchange, and how do you want me to time them on treatment days?
• Should I take my blood pressure medicine the morning of a session?
• What should I eat and drink before and after, and are there any foods or supplements you want me to avoid or include?
• What symptoms in the hours after a session are expected, and which ones should prompt a call that evening or overnight?
• Who do I call, and at what number, if I develop a fever or a problem at the catheter site outside clinic hours?
• How will you monitor my clotting proteins and immune proteins across the course, and will any session be delayed if they fall?
• What are the alternatives to exchange for my condition, and why was this approach chosen for me?
• How long after the course do you expect the underlying condition to respond, and what would make you reconsider the plan?

Write the answers down or ask a companion to. Sessions are long, and information delivered while a needle is going in does not stick.

When to call your doctor

Most tingling and dizziness after therapeutic apheresis fades within hours and needs nothing more than a mention at the next session. A smaller set of signs means the team wants to hear from you the same day, and a few mean calling emergency services rather than waiting.

Call your care team the same day if tingling or cramping persists beyond a few hours after the session, spreads, or is joined by muscle spasms of the hands or feet; if you feel light-headed each time you stand more than an hour after returning home; if you notice unusual bruising, bleeding from gums or nose, blood in urine or stool, or bleeding at an access site that does not stop with ten minutes of firm pressure; if the skin around a catheter or needle site becomes red, warm, swollen or leaks fluid; or if you develop hives, itching or a rash after the session.

Seek emergency care immediately, or call emergency services, for any of the following: difficulty breathing, wheezing, or swelling of the face, lips or throat; chest pain, a racing or irregular heartbeat, or fainting; a fever with shaking chills, particularly if a central catheter is in place; sudden weakness, numbness on one side of the body, facial drooping, slurred speech or confusion; a severe headache unlike your usual headaches; or a catheter that has cracked, come loose or fallen out.

Two rules cut through uncertainty. First, one-sided symptoms are never a citrate pattern and always need urgent assessment. Second, fever with a central line is treated as an emergency until a doctor says otherwise, because immune proteins fall with each exchange and a line infection can move fast.

Every decision about pausing, adjusting or continuing a course belongs to the treating team. Your job is to report accurately and promptly; theirs is to act on it.

Frequently asked questions

What is the most common complication of plasmapheresis?

Symptoms from citrate anticoagulant lowering free calcium, chiefly tingling around the mouth and fingertips, cramping and nausea, are the most frequently reported complication, closely followed by a temporary drop in blood pressure with light-headedness. Both are usually mild and resolve during or shortly after the session once the team slows the run, gives fluid or corrects calcium. Serious complications such as major allergic reactions or significant bleeding are uncommon.

How long do plasmapheresis effects last?

Side effects are short: citrate tingling clears within hours, dizziness typically settles within an hour of lying flat, and fatigue may linger a day or two. The treatment effect is different. One exchange removes about 60 to 65 percent of a bloodstream substance, but tissue stores refill the blood over one to two days, so a course of several sessions is planned, and improvement in the underlying condition usually builds over weeks.

How risky is plasmapheresis?

Plasma exchange carries a low rate of serious harm when performed by trained teams. Large series report overall adverse events in the low single-digit percentages per procedure, most of them mild citrate or blood pressure effects. Risk rises with central venous catheter access, with donor plasma as replacement fluid, and in people with heart or kidney limitations. Procedure-related deaths are very rare and occur almost entirely in critically ill patients.

What are the common side effects of PLEX?

The common side effects of PLEX are tingling of the lips, fingers and toes, light-headedness, muscle cramps or twitching, chills, fatigue, and bruising or soreness at the access site. Hives or itching can occur, more often when donor plasma is the replacement fluid. Clotting proteins and immune proteins fall temporarily after each exchange, which can cause easier bruising and a slightly higher chance of minor infection for a short period.

What is a citrate reaction after plasmapheresis?

A citrate reaction is the cluster of symptoms produced when citrate anticoagulant binds calcium in the blood faster than the body can metabolize it. Early signs are tingling around the mouth and fingertips; if free calcium keeps falling, cramps, hand and foot spasms, nausea, a metallic taste and heart palpitations can follow. Teams treat it by slowing citrate delivery and giving calcium, and it typically resolves within the session or a few hours after.

Why do I feel dizzy after plasma exchange?

Plasma exchange dizziness usually comes from a temporary drop in blood pressure caused by fluid shifting between the circuit, replacement fluid and your own vessels, or from a vagal reflex triggered by needles, anxiety or an empty stomach. Standing quickly after hours reclined adds orthostatic light-headedness. Blood loss is not the cause; the machine returns your red cells. Lying flat, taking fluid, and rising slowly resolve most episodes within an hour.

Why do my legs jerk or cramp after plasmapheresis?

Leg jerks, twitching and cramps during or after an exchange are classic signs of low free calcium from citrate, sometimes with low magnesium as well. Nerves and muscles become more excitable when these minerals dip, and the legs and hands show it first. Reporting them promptly lets the team correct levels, and they usually settle within hours. Persistent or worsening spasms should still be reported the same day.

Is plasmapheresis a surgery?

No. Plasmapheresis is a procedure, not an operation. Blood is accessed through a needle in an arm vein or a catheter placed under local anesthetic, separated in a machine, and returned. There is no incision, no general anesthesia and no surgical recovery. The word surgery appears alongside it online mainly because of billing codes and search habits, not because of anything that happens in the treatment room.

Does plasmapheresis remove my other medicines?

Partly, for some of them. Medicines that are heavily bound to plasma proteins and stay mostly in the bloodstream can be reduced by an exchange, including certain immune-suppressing drugs, some antibiotics and some anticonvulsants. Prescribers handle this by scheduling doses after a session or checking blood levels. Never take extra or change timing on your own; ask the treating team how they want each medicine handled on treatment days.

Can I drive home after plasmapheresis?

Most apheresis units ask that you arrange a ride rather than drive yourself. Sessions last two to four hours, fatigue is common afterward, and residual light-headedness can persist for an hour or more, particularly on standing. Teams also want someone available if symptoms appear on the way home. If your unit has a specific policy, follow it; when in doubt, plan for a companion or other transport.

References

• NHS: Guillain-Barré syndrome, treatment
• NIH National Library of Medicine, StatPearls: Plasmapheresis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.